High expression of LUM was associated with poor efficacy in CESC patients receiving synchronous radiotherapy and chemotherapy, possibly by affecting the PAR and IL1 signaling pathways of the immune landscape (Hu et al., 2023). This evidence concerns the gene LUM and cervical squamous cell carcinoma.